CardioKinetix has developed a novel transcatheter implant called the Parachute Ventricular Partitioning Device (Parachute). The Parachute is designed to be a catheter-based partitioning device deployed within the left ventricle for patients who have developed ischemic left sided heart failure following a heart attack. The Parachute implant partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, which decreases the overall volume and restores a more normal geometry and function in the left ventricle.
Latest funding size
Time since last funding
|over 2 years|
|U.S. Venture Partners (USVP), Cutlass Capital, Lexington Partners, Panorama Capital, Hambrecht & Quist Capital Management, JPMorgan Partners (JPMP), SV Health Investors, New Leaf Venture Partners, Tekla Capital Management, SV Life Sciences, H&Q Healthcare Investors, Edwards Lifesciences|